Co-Authors
This is a "connection" page, showing publications co-authored by Amerta Ghosh and Anoop Misra.
Connection Strength
6.050
-
Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes Metab Syndr. 2021 Jan-Feb; 15(1):215-220.
Score: 0.921
-
Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report. Diabetes Metab Syndr. 2021 Jan-Feb; 15(1):213-214.
Score: 0.920
-
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):917-920.
Score: 0.885
-
Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):577-578.
Score: 0.881
-
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):273-276.
Score: 0.875
-
Management of diabetes mellitus through teleconsultation during COVID-19 and similar scenarios - Guidelines from Indian Council of Medical Research (ICMR) expert group. Diabetes Metab Syndr. 2021 Sep-Oct; 15(5):102242.
Score: 0.240
-
Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases. Diabetes Metab Syndr. 2021 Jul-Aug; 15(4):102151.
Score: 0.237
-
Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification. Diabetes Metab Syndr. 2021 Jan-Feb; 15(1):403-406.
Score: 0.232
-
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):949-952.
Score: 0.222
-
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):303-310.
Score: 0.219
-
Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 May - Jun; 14(3):211-212.
Score: 0.218
-
Case of acute unilateral emphysematous pyelonephritis and bacteraemia on treatment with canagliflozin. Postgrad Med J. 2018 12; 94(1118):714-715.
Score: 0.200